Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVpc Specialty Regulatory News (VSL)

Share Price Information for Vpc Specialty (VSL)

Share Price is delayed by 15 minutes
Get Live Data
11.275    0.00 (0.00%)
Bid:
10.80
Ask:
11.75
Spread: 0.95 (8.796%)
Market Cap: £31.38m
VSL Live PriceLast checked at - London Stock Exchange

Intraday Vpc Specialty Share Chart

Appointment of Audit and Valuation Committee Chair

11 Mar 2021 09:56

RNS Number : 9454R
VPC Specialty Lending Invest. PLC
11 March 2021
 

11 March 2021

 

VPC Specialty Lending Investments PLC (the "Company")

Appointment of Audit and Valuation Committee Chair

 

The Board is pleased to announce that Mr. Oliver Grundy has been appointed as an independent non-executive Director of the Company with effect from 12 March 2021. Following publication of the Company's annual report and accounts for the year ended 31 December 2020, he will succeed Mr. Clive Peggram as Chair of the Audit and Valuation Committee. Mr. Peggram will remain on the Board as an independent non-executive Director. Given Mr. Kevin Ingram's impending retirement, the Board determined that it was appropriate to recruit a qualified accountant with knowledge of the financial services sector and of credit.

Mr. Grundy was an audit partner of Deloitte, LLP for 28 years until his retirement in November 2019. He worked both in London and New York in various roles, including leading Deloitte's Banking Group which comprised a team of 35 partners and 500 professionals. Subsequently he became the audit and advisory partner to significant funds. From 2017 to 2019 he was the Deloitte UK ethics partner, with responsibility for all whistleblowing and conduct matters as well as the firm's Public Interest Review Group.

During his Deloitte career he also had a number of roles at the Institute of Chartered Accountants of England & Wales (ICAEW), including being a Council member, a Disciplinary Committee Tribunal Chairman and serving on the Practice, Risk & Regulation and the Ethics Standards Committees. He is currently a member of the Red Cross International Medical Fundraising Board.

Kevin Ingram, Chairman of the Company, said:

 

"We are delighted Oliver is joining the Board. He brings valuable expertise from the many years he spent in charge of the audits of numerous financial institutions and funds, as well as deep knowledge of complex accounting and disclosure requirements. He also has extensive experience of a wide range of governance matters from his roles at Deloitte and the ICAEW. The Board is grateful to Clive for his service as Chair of the Audit and Valuations Committee and pleased that he will continue to make a contribution as an independent non-executive director."

 

Mr. Grundy does not have any interest in the ordinary shares of the Company.

 

There are no further details or disclosures required under Listing Rule 9.6.13 in respect of Mr. Grundy.

 

Enquiries

For further information, please contact:

 

Victory Park Capital

Brendan Carroll (Senior Partner and Co-Founder)

Gordon Watson (Partner)

via Jefferies or Winterflood (below) info@vpcspecialtylending.com

Jefferies International Limited

Tel: +44 20 7029 8000

Stuart Klein

Neil Winward

Gaudi le Roux

Winterflood Securities Limited

Tel: +44 20 3100 0000

Neil Morgan

Chris Mills

 

Link Company Matters Limited (Company Secretary)

Tel: +44 20 7954 9567

Email: VPC@linkgroup.co.uk

 

About VPC Specialty Lending Investments PLC

VPC Specialty Lending Investments PLC (Company No. 9385218) is a UK listed investment trust focused on asset-backed lending to emerging and established businesses with the goal of building long-term, sustainable income generation. The Company identifies investment opportunities across various industries and geographies to offer shareholders access to a diversified portfolio of opportunistic credit investments originated by non-bank lenders with a focus on the rapidly developing technology-enabled lending sector.

 

Further information on VPC Specialty Lending Investments PLC is available at: http://vpcspecialtylending.com.

 

LEI: 549300UPEXC5DQB81P34

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASFISUFEFSEID
Date   Source Headline
13th May 20267:00 amRNSNet Asset Value(s)
28th Apr 20267:00 amRNSAnnual Financial Report
27th Feb 20264:50 pmRNSDividend Declaration
18th Feb 20267:00 amRNSNet Asset Value(s)
27th Jan 20262:43 pmRNSHolding(s) in Company
22nd Jan 20263:03 pmRNSHolding(s) in Company
12th Jan 20264:01 pmRNSNet Asset Value(s)
4th Dec 20255:51 pmRNSDividend Declaration
4th Dec 20253:13 pmRNSHolding(s) in Company
2nd Dec 20252:57 pmRNSHolding(s) in Company
21st Nov 20257:00 amRNSNet Asset Value(s)
20th Nov 20253:02 pmRNSHolding(s) in Company
27th Oct 20255:35 pmRNSHolding(s) in Company
23rd Oct 20255:20 pmRNSHolding(s) in Company
15th Oct 20253:21 pmRNSHolding(s) in Company
13th Oct 20254:06 pmRNSHolding(s) in Company
2nd Oct 20255:34 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSHalf-year Report
25th Sep 20253:45 pmRNSHolding(s) in Company
24th Sep 20253:25 pmRNSHolding(s) in Company
22nd Sep 20255:35 pmRNSResult of GM
19th Sep 20259:34 amRNSHolding(s) in Company
4th Sep 20252:54 pmRNSNotice of GM
2nd Sep 20259:13 amRNSHolding(s) in Company
28th Aug 20253:51 pmRNSHolding(s) in Company
22nd Aug 20257:00 amRNSNet Asset Value(s)
19th Aug 20254:24 pmRNSHolding(s) in Company
18th Aug 20252:40 pmRNSHolding(s) in Company
14th Aug 20253:08 pmRNSHolding(s) in Company
13th Aug 20253:55 pmRNSHolding(s) in Company
12th Aug 20253:25 pmRNSHolding(s) in Company
11th Aug 20255:39 pmRNSHolding(s) in Company
6th Aug 20253:25 pmRNSBoard Update
26th Jun 20253:59 pmRNSHolding(s) in Company
24th Jun 20251:03 pmRNSHolding(s) in Company
20th Jun 20255:22 pmRNSHolding(s) in Company
12th Jun 202510:51 amRNSResult of AGM
12th Jun 20257:00 amRNSDividend Declaration
2nd Jun 20253:00 pmRNSNet Asset Value(s)
20th May 20257:00 amRNSSecond Return of Capital Exchange Ratio
12th May 20257:00 amRNSSecond Return of Capital through B Share Scheme
8th May 20254:30 pmRNSNotice of AGM
25th Apr 20257:00 amRNSAnnual Financial Report
27th Feb 20257:05 amRNSUpdate
27th Feb 20257:00 amRNSDividend Declaration
19th Feb 20259:59 amRNSNet Asset Value(s)
13th Feb 20254:58 pmRNSHolding(s) in Company
23rd Dec 202411:40 amRNSUpdate
18th Nov 20244:31 pmRNSHolding(s) in Company
13th Nov 20247:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.